X
Xiu Bao Ren
Researcher at Tianjin Medical University Cancer Institute and Hospital
Publications - 1
Citations - 65
Xiu Bao Ren is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Tyrosine-kinase inhibitor & Sunitinib. The author has an hindex of 1, co-authored 1 publications receiving 29 citations.
Papers
More filters
Journal ArticleDOI
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Ai Ping Zhou,Yuxian Bai,Yan Song,Hong Luo,Xiu Bao Ren,Xiuwen Wang,Benkang Shi,Cheng Fu,Ying Cheng,Ji-Yan Liu,Shukui Qin,Jun Li,Hanzhong Li,Xianzhong Bai,Dingwei Ye,Jinwan Wang,Jianhui Ma +16 more
TL;DR: The clinical efficacy of anlotinib was similar to that of sunitinib as the first-line treatment for mRCC, but with a more favorable safety profile.